The tumour-killing immune response can be inhibited by cancer cells that express regulators of immune checkpoints such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), T cell immunoglobulin mucin-3 (TIM-3) and PD-L1 [112]. This evidence concerns the gene HAVCR2 and neoplasm.